Offering What Other Machines Cannot
"The success of this unique perfusion system—developed over a four-year period by a group of surgeons, biologists and engineers—paves the way for many new applications in transplantation and cancer medicine helping patients with no liver grafts available," explained Prof. Pierre-Alain Clavien, Chairman of the Department of Surgery and Transplantation at the UniversityHospital Zurich (USZ). When the project started in 2015, livers could only be kept on the machine for 12 hours. The seven-day successful perfusion of poor-quality livers now allows for a wide range of strategies, e.g. repair of preexisting injury, cleaning of fat deposits in the liver or even regeneration of partial livers.
Liver4Life: A project from Wyss Zurich
The Liver4Life project was developed under the umbrella of Wyss Zurich institute, which brought together the highly specialized technical know-how and biomedical knowledge of experts from the UniversityHospital Zurich (USZ), ETH Zurich and the University of Zurich (UZH). "The biggest challenge in the initial phase of our project was to find a common language that would allow communication between the clinicians and engineers," explained Prof. Philipp Rudolf von Rohr, professor of process engineering at ETH Zurich and co-leader with professor Clavien of the study now published in Nature Biotechnology.
Technology with Great Potential
The inaugural study shows that six of ten perfused poor-quality human livers, declined for transplantation by all centers in Europe, recovered to full function within one week of perfusion on the machine. The next step will be to use these organs for transplantation. The proposed technology opens a large avenue for many applications offering a new life for many patients with end-stage liver disease or cancer.